To determine whether atractylenolide I inhibits NLRP3 inflammasomes in vivo, we evaluated the expression of NLRP3 in the AOM/DSS mice model by immunohistochemistry (IHC) and Western blotting. The gene discussed is NLRP3; the disease is infectious otitis media.